- Country: Slovakia
- Summary: Antineoplastic and Immunomodulating Agents
- SKT Ref No: 113542508
- Deadline: 21 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 505274.70
- Notice Type: Tender
- Document Ref. No.: 44554-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Part 1
Trastuzumab deruxtekanplc ifc1x100 mg (drug.inj.skl. amber.)110
Part 2
Daratumumabsol inj1x15 ml/1800 mg (drug.inj.skl.)90
Antineoplastic and immunomodulating agents part no. 1
Part 1
Trastuzumab deruxtekanplc ifc1x100 mg (liek.inj.skl. amber.)110
Antineoplastic and immunomodulating agents part - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAntineoplastic and Immunomodulating Agents - Slovakia Tender
The FACULTY HOSPITAL WITH POLYCLINIC ŽILINA, a Government sector organization in Slovakia, has announced a new tender for Antineoplastic and Immunomodulating Agents. This tender is published on SlovakiaTenders under SKT Ref No: 113542508 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-21.
The estimated tender value is EUR 505274.70, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
